Print Page

被 發 現 含 有 未 標 示 西 藥 的 產 品

Singapore: HSA Alert: Tian Ma Tu Chung Seven Leave Ginseng, Perliere Mimi Pearl Cream, Impactra found to contain potent medicinal ingredients (English only)
The Health Sciences Authority (HSA) is alerting members of the public not to purchase or use the following health or cosmetic products. They contain potent medicinal ingredients which are prohibited in such products. Two of these products have caused serious adverse effects in consumers. The third product contained dangerously high levels of a potent medicine used to treat erectile dysfunction. The affected products are:
- Tian Ma Tu Chung Seven Leave Ginseng (天麻杜仲七葉參): contains chlorpheniramine and dexamethasone
- Perliere Mimi Pearl Cream: contains clobetasol propionate, ketoconazole, sulfamethoxazole and trimethoprim
- Impactra: contains chloropretadalafil, sildenafil and tadalafil

A male patient in his 50s developed abnormal blood cortisol levels following long-term consumption of Tian Ma Tu Chung Seven Leave Ginseng, which was purchased in Malaysia. HSA tested this product and detected two medicinal ingredients: chlorpheniramine, an antihistamine, and dexamethasone, a potent steroid. Dexamethasone can only be obtained through prescription by a doctor while chlorpheniramine should be obtained from a doctor or pharmacist. Long-term unsupervised use of steroids like dexamethasone can cause increased blood glucose levels (which may lead to diabetes), Cushing’s syndrome (a round face or ‘moon face’ appearance and upper body obesity with thin limbs), and other serious adverse effects.

A woman in her 30s developed symptoms of redness, extreme itchiness and burning sensation after she stopped using Perliere Mimi Pearl Cream. She had purchased the product online and used it for over two years. HSA’s tests found that the product contained four medicinal ingredients: trimethoprim and sulfamethoxazole, which are antibiotics; ketoconazole, an anti-fungal medicine; and clobetasol propionate, a potent steroid. These ingredients can pose serious health risks if used without medical supervision. Her skin specialist confirmed that she had developed steroid withdrawal symptoms.

During HSA’s routine surveillance of products in the market, Impactra was detected to contain sildenafil, tadalafil and chloropretadalafil. These are prescription medicines used for the treatment of male erectile dysfunction. Tadalafil was present in high levels of up to 10 times the maximum daily dose. These high levels can cause serious adverse effects such as low blood pressure, stroke, heart attack, and painful and exceedingly long erections (priapism) which can lead to permanent erectile dysfunction if left untreated. Impactra was sold by Gold Tree Pte Ltd and marketed for male sexual enhancement.

Please refer to the following website in HSA for details:

In Hong Kong, the above products are not registered pharmaceutical products.

Ends/Tuesday, Feb 11, 2020
Issued at HKT 15:00